Loading
Epirubicin (Ellence) is a close relative of doxorubicin used mainly after breast cancer surgery when lymph nodes are involved, and in stomach cancer regimens; it is a little kinder to the heart.
Epirubicin was approved by the FDA in 1999 as a component of adjuvant therapy for axillary node-positive breast cancer, based on the Canadian MA.5 (CEF versus CMF) and French FASG trials in which epirubicin-containing regimens improved relapse-free and overall survival. Outside the US it has been used far more widely since the 1980s, including in the ECF/EOX regimens for gastro-oesophageal cancer (REAL-2) and in FEC-docetaxel sequences for breast cancer. Cardiotoxicity is cumulative-dose dependent (the label caps lifetime exposure at 900 mg/m2), secondary acute myeloid leukaemia is a recognised late effect, and it is a vesicant.
4'-epimer of doxorubicin; intercalates DNA and inhibits topoisomerase II, with less cardiotoxicity per milligram than doxorubicin.
1.Epirubicin slips into a pocket on its target.
| Region | Year | Indication |
|---|---|---|
| US | 1999 | Adjuvant therapy for axillary node-positive breast cancer |
Read for the class this product belongs to (anthracyclines) unless the answer names the product. Population figures from the cohorts named, not a prediction for one person. Blank where no source gives a recovery figure.
Country and place are remembered in this browser only. A postcode is sent to OpenStreetMap's Nominatim service to find coordinates when you press the button; nothing else leaves your device.
Query for this drug: (TITLE:"Epirubicin" OR ABSTRACT:"Epirubicin" OR TITLE:"Ellence" OR ABSTRACT:"Ellence" OR TITLE:"Pharmorubicin" OR ABSTRACT:"Pharmorubicin") AND (cancer OR tumor OR tumour OR oncology OR carcinoma OR lymphoma OR leukemia OR leukaemia OR myeloma OR sarcoma OR melanoma OR glioma). Results are unfiltered search hits about Epirubicin, not a curated reading list.
Shares Pfizer (incl. Seagen), Topoisomerase-I inhibitors (and ADC payloads), Cytotoxic chemotherapy and the tag generic.
Shares Doxorubicin, Topoisomerase-I inhibitors (and ADC payloads), Cytotoxic chemotherapy and the tag generic.
Shares Trial Studying Chemotherapy in Nigerian Women With Triple Negative Breast Cancer, NordicTrip, a Translational Study of Preoperative Chemotherapy in TNBC, FLOT4-AIO: perioperative FLOT versus ECF/ECX for resectable gastric or gastro-oesophageal junction adenocarcinoma, FLOT4-AIO and the tag generic.
Shares Topoisomerase-I inhibitors (and ADC payloads), Cytotoxic chemotherapy and the tag generic.
Shares FLOT4-AIO, Gastric & gastro-oesophageal junction cancer, Cytotoxic chemotherapy and the tag generic.
Shares Gastric & gastro-oesophageal junction cancer, Cytotoxic chemotherapy and the tag generic.
Shares HR-positive / HER2-negative breast cancer, Cytotoxic chemotherapy and the tag generic.
Shares Cytotoxic chemotherapy and the tag generic.